Sterilization validation is one of the final steps before a medical device moves toward regulatory submission or commercialization.
For many teams, it also becomes a bottleneck.
Validation studies can take months to complete, especially when a new sterilization cycle must be developed from the ground up. But in many cases, there is a more efficient path forward:
Adopting into an existing validated ethylene oxide (EO) sterilization cycle.
Why Sterilization Validation Takes Time
Sterile medical devices must demonstrate a Sterility Assurance Level (SAL) of 10⁻⁶, following standards from the International Organization for Standardization for EO and radiation sterilization.
A typical validation program includes:
- Bioburden testing
- Half-cycle studies
- Sterility testing
- Residual analysis (for EO)
These activities require coordination across sterilization providers, microbiology labs, and engineering teams. When a new cycle is needed, the full process must be developed and documented, adding significant time to the program.
What Is EO Cycle Adoption?
EO cycle adoption allows a new device to be sterilized using an existing, validated EO sterilization cycle.
Instead of starting from scratch, the device is evaluated to determine whether it can be processed within established parameters. If the materials, geometry, and packaging align with the validated cycle, the validation effort can be significantly reduced.
This approach is commonly used for devices with similar:
- Materials
- Device configurations
- Packaging systems
How EO Cycle Adoption Reduces Timeline
When adopting into an existing EO cycle, the focus shifts from full cycle development to compatibility verification.
Rather than repeating every validation step, teams typically need to demonstrate:
- Bioburden compatibility
- Sterility assurance under the existing cycle
- Acceptable EO residual levels
Because the sterilization process itself is already validated, these studies are more targeted and efficient.
For many programs, this approach can remove months from the sterilization validation timeline.
When EO Cycle Adoption Is a Good Fit
EO cycle adoption is most effective when the device:
- Uses materials compatible with EO sterilization
- Fits within established packaging configurations
- Falls within validated sterilization load parameters
The key is evaluating sterilization strategy early. Identifying compatibility during development can determine whether adoption is viable and avoid delays later.
Sterilization Support at Medical Murray
Medical Murray supports sterilization validation across EO, gamma, and electron beam methods.
While sterilization is performed through qualified contract partners, our team develops validation strategies, writes protocols, coordinates testing, and prepares documentation for regulatory submission.
A key advantage for many programs is access to existing validated EO sterilization cycles. When a device is a fit, adoption into these cycles can significantly reduce both timeline and cost.
Plan Ahead to Avoid Delays
Sterilization is often treated as a final step, but it should be considered early in development.
Material selection, device design, and packaging all influence sterilization compatibility. Evaluating these factors upfront makes it easier to determine whether EO cycle adoption is possible and helps prevent delays later in the program.
Streamlining Sterilization Validation
Sterilization validation does not have to be a bottleneck.
With the right strategy, including early planning and EO cycle adoption, teams can reduce timelines and move more efficiently toward regulatory submission.
At Medical Murray, we support verification and validation (V&V) programs including sterilization validation, packaging validation, and mechanical testing to help device programs progress smoothly from development to commercialization.